925.32MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US00650F1093
CUSIP
00650F109
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
1.52
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.34
Wall Street Target Price
7.4167
EPS Estimate Current Year
-1.1106
EPS Estimate Next Year
-0.8546
EPS Estimate Current Quarter
-0.29
EPS Estimate Next Quarter
-0.29
Most Recent Quarter
-
Revenue TTM
177,282,000
Gross Profit TTM
-13,657,000
EBITDA
-146,946,000
Profit Margin
-110.13%
Return On Assets TTM
-16.37%
Return On Equity TTM
-66.76%
Revenue Per Share TTM
1.211
Qtly Revenue Growth YOY
22.50%
Diluted Eps TTM
-1.34
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
5.2195
Price Book MRQ
4.1351
Enterprise Value Revenue
4
Enterprise Value EBITDA
0
474.37
2.72%787.27
1.18%207.70
1.01%525.60
0.00%170.35
-5.37%616.16
-1.22%89.57
-0.99%255.18
-0.43%121.33
-0.33%98.13
-0.03%